Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Brontictuzumab Biosimilar – Anti-NOTCH1 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG2-lambda |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Brontictuzumab Biosimilar - Anti-NOTCH1 mAb - Research Grade |
|---|---|
| Source | CAS 1447814-75-6 |
| Species | Humanized |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Brontictuzumab,OMP-52M51,NOTCH1,anti-NOTCH1 |
| Reference | PX-TA1347 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG2-lambda |
| Clonality | Monoclonal Antibody |
Description of Brontictuzumab Biosimilar - Anti-NOTCH1 mAb - Research Grade
General information on Anti-NOTCH1[Homo sapiens] (Brontictuzumab) Monoclonal Antibody
Brontictuzumab has been investigated in the treatment of adenoid cystic carcinoma, relapsed or refractory solid tumors, and lymphoid malignancies.
Related products
Isotype Control
Human IgG2 Isotype Control antibody (HyHEL-10)
PTX17900 215$Contact us
Send us a message from the form below
Reviews
There are no reviews yet.